Common deficiencies in abbreviated new drug applications: part 1: Drug substance

被引：0
|
作者：
Srinivasan, Aloka [1 ]
Iser, Robert [1 ]
机构：
[1] Office of Generic Drugs, Office of Pharmaceutical Science, US Food and Drug Administration S Center for Drug Evaluation and Research, United States
来源：
Pharmaceutical Technology | 2010年 / 34卷 / 01期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：50 / 59
相关论文
共 50 条
  • [31] Regulatory consideration for structural characterization of small molecule drug substances in type II drug master files (DMF) supporting abbreviated new drug applications (ANDAs)
    Wang, Jizhou
    Takiar, Neeru
    Zhang, Huyi
    Wang, Zhengfu
    Shi, Qian
    Senanayake, Chandrawansha
    Skanchy, David
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [32] NEW DRUG APPLICATIONS
    MEYER, GF
    SCIENCE, 1991, 253 (5015) : 17 - 17
  • [33] Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective
    Henningfield, Jack E.
    Ashworth, Judy
    Heal, David J.
    Smith, Sharon L.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2023, 37 (01) : 33 - 44
  • [34] Advantages of using an abbreviated dossier for drug master file applications in Taiwan
    Sun, I-Chen
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2016, 80 : 310 - 313
  • [35] Designation of a new drug as a controlled substance
    Lee, Mi Soon
    Ahn, Wonsik
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2011, 54 (02): : 189 - 196
  • [36] ABBREVIATED NEW DRUG APPLICATION REGULATIONS - CHEMISTRY, MANUFACTURING, AND CONTROLS
    PATEL, RM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 4 - CHAL
  • [37] The Prevalence of Several Treatments in Preventing the Back Conversion of Acyl Glucuronide Metabolites in Abbreviated New Drug Applications
    Taur, Jan-Shiang
    Zhao, Chunsheng
    Darna, Mahesh
    Chang, Yang
    Lu, Yang
    Mao, Jinzhe
    Cai, Wendy
    Ren, Ke
    Braddy, April C. C.
    AAPS JOURNAL, 2023, 25 (02):
  • [38] The Prevalence of Several Treatments in Preventing the Back Conversion of Acyl Glucuronide Metabolites in Abbreviated New Drug Applications
    Jan-Shiang Taur
    Chunsheng Zhao
    Mahesh Darna
    Yang Chang
    Yang Lu
    Jinzhe Mao
    Wendy Cai
    Ke Ren
    April C. Braddy
    The AAPS Journal, 25
  • [39] Advances in Drug Analysis - New Analytical Technologies and their Applications (Part II)
    Ozkan, Sibel A.
    CURRENT PHARMACEUTICAL ANALYSIS, 2017, 13 (02) : 99 - 99
  • [40] An FDA analysis of clinical hold deficiencies affecting investigational new drug applications for oncology products
    Manning, Michael L.
    Thompson, Matthew D.
    Saber, Haleh
    Maher, Virginia E.
    Crich, Joyce Z.
    Leighton, John K.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2020, 110
12345